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EFFECT OF CHRONIC TREATMENT WITH A CYCLOOXYGENASE 
INHIBITOR ON REPRODUCTIVE PARAMETERS IN MALE RAT 
Sheikh A. Saeed, Naheed Anwar, Khalid M. Khan, Noorjehan Sarfraz 
Department of Biological & Biomedical Sciences, Aga Khan University, Karachi, Pakistan 
Background: Indomethacin is a member of non-steroidal anti-inflammatory drugs (NSAIDs) 
commonly used for treatment of gout, arthritis, and other inflammatory conditions. It has been shown to 
inhibit ovarian prostaglandins synthesis in mammals, birds, fish and reptiles. However, the effects of its 
chronic administration on male reproductive functions remain largely unknown. Using rat as a model, 
we studied the effect of chronic treatment with indomethacin on the male reproductive system. 
Methods: Testosterone was measured in the serum, testicular tissue, and testicular interstitial fluid by 
radioimmunoassay. Moreover, we also studied the direct effect of indomethacin in vitro on luteinizing 
hormone stimulated testosterone secretion from the Leydig cells isolated from various treatment 
groups. Results: Indomethacin treatment for 50 days caused a significant but reversible decrease in 
prostate weight, epididymal sperm reserves and sperm motility score compared with control rats 
(p<0.05). In vitro stimulation of Leydig cells isolated from treated rat’s testes with luteinizing hormone 
(250 µIU) produced significantly reduced testosterone compared with cells from control groups 
(p<0.05). Furthermore, stimulatory effect of luteinizing hormone on the control Leydig cells was 
significantly reduced when these cells were challenged with luteinizing hormone in the presence of 
indomethacin, (p<0.05). Testosterone concentration in the testicular tissue and testicular interstitial fluid 
reduced after indomethacin treatment (p<0.05). Conclusion: Due to its significant inhibition of key 
reproductive hormones, indomethacin effectively inhibits reproductive functions if used on a long-term 
basis. In his study, we have identified potential risks in the long-term use of cyclooxygenase inhibitors.  
Keywords: Cyclooxygenase inhibitor, reproductive functions, male rats 
INTRODUCTION 
Prostaglandins (PG) play substantial roles in regulating 
reproductive activity in both male and females.1,2 
Prostaglandins are abundantly found in the male 
reproductive tract.3  Prostaglandins E and F play an 
important role in sperm metabolism and its functions4,5, 
and also increase the contractility of the epididymal 
tubule smooth muscle layer6. Moreover, systemic 
administration of PGs increases circulating levels of 
Prolactin (PRL)7,8, Follicle Stimulating Hormone 
(FSH)7 and Luteinizing Hormone ( LH),9,10   
It is clear that, chemical inhibition of the PGs 
have dramatic effect on female reproduction.11 
Indomethacin has been shown to inhibit ovarian 
prostaglandins synthesis in mammals12, birds13, fish14, 
and reptiles15. Inhibition of PG biosynthesis by 
treatment with indomethacin or other NSAIDs during 
pro-oestrus, estrus and metestrus phases, prevents 
ovulation in rats16 In vitro  and in vivo treatment with 
indomethacin has shown inhibitory effect on basal and 
GDF-9-stimulated progesterone in pre-ovulatory 
Granulosa cell culture system.17 Moreover, if 
administered at the time of implantation in rabbits 
indomethacin decreases plasma progesterone 
concentration and the number of viable embryos.18 
Prolonged treatment with indomethacin also reduces 
fertility in female animals.19 We have demonstrated 
previously20 that chronic treatment of male rats with 
indomethacin effectively inhibits steroidogenesis at the 
level of testis, which leads to rise in plasma luteinizing 
hormone (LH). 
Indomethacin, a non-steroidal anti-
inflammatory drug (NSAIDs), inhibits both isoezymes, 
COX1 and COX2.21,22 Inhibition of COX-1 may result 
in adverse effects on the gastro-intestinal tract and the 
renal functions. COX-2 inhibition leads to anti-
inflammatory effect23 Indomethacin is prescribed for 
alleviation of pain, tenderness, inflammation, and 
stiffness caused by gout, arthritis, and other 
inflammatory conditions.17 Despite its well-known role 
as a PG inhibitor, indomethacin is used for the long-
term treatment of several inflammatory conditions, the 
effects of its chronic administration on male 
reproductive functions remains largely unknown. In this 
study, we have investigated the effect of chronic 
treatment with a cyclooxygenase inhibitor 
(indomethacin) on reproductive functions. Moreover, 
we looked at direct in vitro effects of indomethacin on 
LH stimulated testosterone secretion from Leydig cells. 
MATERIAL & METHODS  
Twenty adult virgin male rats (Wistar, average weight 
171±23 g) about 90 days old were randomly allocated to 
two groups of 10 each. These rats were obtained from 
AKU animal facility where they were maintained under 
standard conditions of 14 hr light and 10 hr dark cycle at 
23 ºC. The rats had free access to food and water. 
Ten rats received daily subcutaneous injections 
of indomethacin suspension (Sigma Chemical Co., St 
Louis, MO, USA) at a dose of 2 mg/Kg body weight in 
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200µl saline for 50 days. This dose was selected after 
preliminary tests with different doses. Control (n=10) 
received the same volume of saline. Treatment plan is 
given in the figure-1. At the end of the treatment rats 
were euthanised. Blood, was collected and accessory 
reproductive organs (testes, prostate, seminal vesicle, 
and epididymes) were dissected, removed and weighed. 
A small piece of testes was cut and fixed in 5% 
gluteraldehyde for histological studies. 
 
Figure-1: Treatment Plan 
Leydig cell isolation was carried our according 
to the procedure described previously20 Cell viability 
(>80% viable) was determined by counting number of 
cells excluding trypan blue on a haemocytometer.24 
The Leydig cells from each rat in all groups 
were incubated with LH and indomethacin, alone or in 
combination (no stimulation, LH 250 µg or 
LH250+indo 40 µg). LH dilutions were made in the 
incubation medium and indomethacin was dissolved in 
the organic solvent dimethylsulfoxide (DMSO, Sigma, 
2 mg/ml). LH (NIDDK-hLH-B-SIAFP2) was a gift 
from National Hormone and Pituitary Programme 
California, USA (potency 6100 IU/mg in terms of 
WHO IRP 68/40). 
TIF was collected as previously described with 
some modifications.25–28 Briefly, one testis was used to 
collect TIF and it was given small 2 to 4 mm incisions at 
the caudal ends of the testes capsules. The testis was 
suspended 1 cm above 20 µl of 0.1 M acetic acid in 
glass tubes overnight (18–20 hr) at 4 ºC. The TIF 
volumes were then carefully measured and stored at -70 
ºC till testosterone was measured in them by 
radioimmunoassay. 
One epididymis from each rat was removed to 
determination the epididymal sperm reserve by a 
technique modified from.29 Each epididymis was 
homogenized using a tissue homogeniser as described 
by.30 Homogenate was diluted 1:1 and the epididymal 
sperm reserve was calculated by using a 
haemocytometer. 
Sperm motility score was determined through 
a technique described by.30 Sperm samples from the 
contralateral vas deferens were used for epididymal 
sperm reserve assessment. Each sample was diluted in 
0.5 ml of M-199 (Sigma) at 37 ºC for 10 min, and the 
percentage of motile sperm and the degree of their 
motility (expressed in percent) were determined by 
phase contrast microscopy. 
Testosterone was measured in the incubation 
medium directly by a highly sensitive RIA according to 
WHO protocol, using 3H labelled testosterone, as tracer 
and a highly specific antiserum for testosterone from 
Guildhay UK.  Serum and testicular testosterone was 
measured in extracted samples, whereas RIA reagents 
were directly added to tubes containing incubation 
medium. After addition of all the reagents, tubes were 
incubated for 30 min. at 4 ºC. The bound and unbound 
fractions were separated by the addition of 0.1% 
charcoal. Radioactivity was measured in a liquid 
scintillation counter. Testosterone concentration was 
calculated by logit-log transformation.31 
The sensitivity of testosterone assay was 
0.0125 ηg and the intra-assay coefficient of variation 
was <10%. The levels of testosterone in the media were 
expressed as ηg/ml. 
Testicular tissue was prepared for histology by 
epoxy resin sectioning. Briefly, a small piece of testes 
was fixed in 100 mM cold gluteraldehyde and 
cacodylate buffer pH 7.2. Ascending grades of acetone 
were used to dehydrate the tissue. Tissue was infiltrated 
by the mixtures of acetone and ACM mixture and 
embedding was done in ACM II mixture. One micron 
thick sections were cut in Nova Ultra tome and stained 
with 1% toluidene blue in 1% borax. 
All The data obtained were expressed as 
Mean±SD. The data was analysed for differences 
among treatment and from its withdrawal, using 
Student’s t-test. A ‘p-value’ of 0.05 or less was 
considered significant. 
RESULTS 
Table-1 shows the body weights and the various 
reproductive parameters. There was a no significant 
difference in the body weight between CI and TI. 
Indomethacin treated rats did not show any significant 
effect on testicular and relative weight of seminal 
vesicles but this treatment significantly reduced relative 
prostrate weight, compared to their respective control. In 
the recovery group, there was a significant difference 
(p<0.05) between body weights of control CII and its 
respective treated group TII.  In these groups, there was 
a significant difference (p<0.05) between the testicular 
weights and in the weights of seminal vesicles.  
Conversely, no significant difference was 
noted between weights of the pituitaries in either 
treatment or the reversal groups compared with their 
respective controls. 
Relative epididymal weights in the reversal 
group treated animals, TII were significantly (p<0.05) 
different compared with their controls, CII. Treatment 
Control 
Treated 
50 
 
100 Days 0 
Indomethacin  ON Indomethacin OFF 
T1 
T 2 
C 1 
C 2 
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with indomethacin and its termination, significantly 
(p<0.05) altered the epididymal sperm reserves 
compared to their respective controls. 
The mean sperm motility score of male rats 
administered indomethacin for 50 days decreased 
significantly (p<0.01) compared with the control 
animals. Reversal group, TII showed significant 
(p<0.01) restorative effect on mean sperm motility 
score, compared with TI. However, this score was still 
significantly lower (p<0.01) compared with the 
respective control group CII. 
Results of the in vitro stimulation of Leydig 
cells from control animals and treated rats are given in 
the Table-2. In vitro stimulation of Leydig cells from 
control animals, with LH 250 µIU resulted in 
significantly higher (p<0.05) testosterone secretion 
compared with control un-stimulated cells from control 
animals. Stimulation of Leydig cells from indomethacin 
treated animals, with 250 µIU LH produced 
significantly (p<0.05) less testosterone as compared 
with its control group. In order to investigate effect of 
short-term in vitro  treatment of Leydig cells with 
indomethacin on testosterone secretion, Leydig cells 
from the control and the treated rats were stimulated 
with LH 250 µIU with or without indomethacin 40 µg.  
Treatment with indomethacin significantly 
(p<0.05) reduced testosterone secretion in response to 
stimulation with LH 250 µIU. However, when Leydig 
cells from indomethacin treated rats were stimulated 
with LH 250 µIU, their steroidogenic response was 
significantly (p<0.05) reduced compared with LH 
stimulated Leydig cells from the control animals. In the 
group TII, in vitro  treatment with LH 250 µIU showed 
a significant (p<0.05) stimulatory effect compared with 
control. Although statistically at a non-significant level, 
LH 250 stimulated increase in the secretion of 
testosterone was inhibited both in TI and TII groups by 
indomethacin  treatment in vitro. 
Table-3 shows the concentration of 
testosterone in testicular tissue, TIF and serum. The 
testicular tissue testosterone concentration significantly 
decreased (p<0.05) in the treated group compared with 
control. Similarly, TIF testosterone concentration in 
indomethacin treated animals was significantly lower 
(p<0.05) compared with controls. Testosterone 
concentration in testicular interstitial fluid in TII group 
was significantly higher (p<0.05) compared with the 
treated animals. Serum testosterone in the treated group 
was significantly lower (p<0.05) compared with control. 
However, there were no significant differences in serum 
testosterone levels between CII and TII or TI and TII. 
Table-1: Effect of Chronic Treatment With Indomethacin on Some Reproductive Parameters in the Male Rat 
Treatment 
(n =5) 
Body 
Weight (g) 
Relative 
Testes wt. 
(g/100g of b.w) 
Relative 
Prostate wt. 
 (g/100g  of b.w) 
Relative Seminal 
vesicle wt.  
(g/100g of b.w) 
Relative 
Epididymis wt.  
(g/100g of b.w) 
Relative 
Pituitary wt.  
(g/100g of b.w) 
Epididymal 
Sperm 
Reserve 10-6 
Sperm 
Motility 
Score 
CI 370±50 0.42±0.02 0.19±0.01 0.1±0.01 0.13±0.01 2.0±0.2 5.3±0.55 1730±180 
TI 374±32 0.47±0.02 0.15±0.01* 0.1±0 0.13±0 2.2±0.16 3.8±1.1* 465±60* 
CII 436±12‡ 0.35±0.02‡ 0.18±0.04 0.07±0‡ 0.11±0‡ 1.8±0.2 7.3±0.7 1860±147 
TII 334±44† 0.42±0.05† 0.18±0.05 0.1±0.0† 0.15±0.01†§ 2.0±0.3 9.2±1.1†§ 1109±199†§ 
*Significant difference between CI & TI, †Significant difference between CII & TII, ‡Significant difference between CI & CII, §Significant 
difference between TI & TII. Key: CI (Saline treated), TI (Indomethacin treated), CII (Saline discontinued), TII (indomethacin discontinued) 
Table-2: Effect of Indomethacin on LH Stimulated Testosterone secretion from the Leydig Cells 
In vitro Treatment In vivo Treatment 
Treatment (n=3 ) Control I TI Control II TII 
Control 1.39±0.6 0.8±0.3 1.2±0.5 0.7±0.1 
LH 250 µIU 2.6±0.5* 1.1±0.2*†  1.8±0.8 1.1±0.2* 
Indo. 40 µg 1.1±0.4 0.8±0.3 1.2±0.5 0.6±0.3 
LH 250 ± Indo. 40 1.3±0.7‡ 0.9±0.3 1.5±0.6 0.8±0.3 
* Significant differences between Control & LH 250, †Significant difference between LH 250 in control I TI, ‡Significant difference between LH 
250 & LH 250+Indo.40 
Table-3: Testosterone Concentration in Serum, Testicular Tissue and Testicular Interstitial Fluid 
Treatment Testes-T (ηg/100 mg) TIF –T (ηg/ml) Serum-T (ηg/ml) 
CI 114±33 105.7±33 5.1±1.5 
TI 51±14* 51±14.6* 3.7±0.8* 
CII 140±35 112.3±34.6 4.7±1.7 
TII 101±33†‡   92.1±23†   3.4±2 
*Significant differences between CI & TI, †Significant differences between TI & TII, ‡Significant differences between CII & TII 
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Figure-2 shows the transverse section of 
seminiferous tubule from a control rat.  Note the 
presence of a single layer of myoepithelial cells (MC).  
Germinal epithelium is arranged compactly and 
vesicular nuclei exhibit DNA synthetic activity.  
Spermatogonia with dark nuclei (Sg) are present along 
the basement membrane. Primary spermatocytes (PS) 
show typical condensation of chromosomes depicting 
meiotic activity.  Toward the lumen spermatids and 
sperms (Sp) are in various stages of development. 
 
Figure-2: Control 
Figure-3 shows the transverse section of 
seminiferous tubule after treatment.  Note the presence 
of a single layer of MC.  The organization of the 
germinal epithelium (GE) is disrupted.  Large spaces 
have appeared in between germinal cells and 
degenerating cells are prominent.  Absence of meiotic 
activity indicates the negative effect of treatment on the 
cell cycle in the lineage of spermatocytes. 
 
Figure-3: Treatment with Indomethacin for 50 days 
The micrograph in Figure-4 shows transverse 
section of seminiferous tubule 50 days after termination 
of treatment.  Note the presence of a single layer of 
myoepithelial cells (arrowheads).  Spermatogonia (Sg) 
and primary spermatocytes exhibit normal nuclear 
profiles indicating normal cell cycle activity.  
Intercellular spaces in the germinal epithelium are 
eliminated and the luminal side of the epithelium shows 
maturation of spermatids and sperms. 
 
Figure-4: Reversal Group 
DISCUSSION 
Data from our study demonstrates that indomethacin 
treatment decreases prostate weight, epididymal sperm 
reserves and sperm motility score but cessation of 
treatment restores the weight of testis, relative weight of 
prostate, epididymes and epididymal sperm reserves, as 
well as sperm motility score. Epididymal tubule passage 
is an important process that leads to the formation of a 
correct milieu for sperm maturation and storage.32 
Significant difference between the epididymal sperm 
reserve in treated and reversal group shows a bounce 
back effect of removal of treatment on the 
spermatogenesis. The histological evidence discussed 
later, also supports these results.  
Previous studies20 showed an increase in plasma 
LH during treatment. A drop in T levels by a negative 
feedback system causes an elevation of LH from 
pituitary. This further explains that indomethacin has a 
direct effect at the level of testes rather than pituitary.  
Sperm maturation is a complex process and 
prostaglandins play an important role by regulating 
luminal microenvironment. In basal conditions in 
addition to the epididymis COX-2 mRNA and protein is 
also expressed in a wide range of tissues like the lung, 
testis, brain, and prostate under.33,34 More than 90% of 
the extra testicular sperms are stored in epididymis.35 
Inhibition of the COX pathway may result in disruption 
of epididymal microenvironment. Thus, the decrease in 
epididymal weight was likely due to a reduction in 
epididymal sperm reserves.  
Testosterone concentration measured in 
testicular tissue and testicular interstitial fluid was 
reduced during treatment and recovered during the 
withdrawal period to almost pre-treatment levels. The 
same pattern was observed in serum testosterone 
concentration. Testosterone secretion and TIF formation 
are the two fundamental regulatory aspects of normal 
testicular function. There is evidence that AA and its 
metabolites are involved in testicular functions. It has 
been shown that LH is responsible for rapid release of 
AA from Leydig cells36 related to concentration of 
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membrane receptors of LH-Hcg37. In vitro data from 
this study also supports our observation of indomethacin 
induced reduction in serum and TIF testosterone 
secretion. Leydig cells from control rats stimulated with 
LH in the presence and absence of indomethacin 
showed significant difference in testosterone production. 
Similarly, Leydig cells from Control group and 
indomethacin treated rats responded significantly 
different to in vitro LH stimulation.  
Our histological evidence from testicular 
studies further supports this finding. Figure 1 shows the 
transverse section of seminiferous tubule from a control 
rat.  It presents the normal architecture of the testicular 
tissue showing a single layer of myoepithelial cells and 
germinal epithelium arranged compactly with vesicular 
nuclei exhibiting DNA synthetic activity.  Dark 
nucleated spermatogonia (Sg) are visible along the 
basement membrane and the primary spermatocytes 
(PS) show typical condensation of chromosomes 
depicting meiotic activity.  Towards the lumen, 
spermatids and sperms (Sp) are in various stages of 
development. In the indomethacin treated rats, (Figure 
2) organization of the germinal epithelium is disrupted.  
Large spaces can be seen in between germinal cells and 
degenerating cells are prominent. Treatment also led to 
a negative effect on the cell cycle in the lineage of 
spermatocytes, indicated by the absence of meiotic 
activity. This study also shows that the negative effects 
of indomethacin treatment are reversible. Figure 3 
shows the transverse section of seminiferous tubule 50 
days after termination of treatment.  One can note a 
single layer of myoepithelial cells, and spermatogonia 
and primary spermatocytes exhibiting normal nuclear 
profiles indicating normal cell cycle activity.  The 
germinal epithelium is without the intercellular spaces 
noted previously in the treated testes and the luminal 
side of the epithelium shows maturation of spermatids 
and sperms.  
CONCLUSIONS 
In conclusion, cyclooxygenase inhibitors undoubtedly 
disrupt the homeostatic processes by inhibiting the 
essential reproductive hormones. Indomethacin can 
effectively inhibit reproduction on a long-term basis. 
The most concerning characteristic of NSAIDs is that 
the concentration which is required to inhibit PG 
biosynthesis are usually much lower than those essential 
for their other pharmacological effects. The long-term 
use of such treatment strategies would require a better 
therapeutic alternate. Interestingly, the data provides 
insights for possibility to develop a therapeutic 
treatment to induce a reversible inhibition of 
reproductive functions. Our progress in identifying 
potential risks for long-term effects of indomethacin in 
male rats raise question about the long-term use of 
compounds similar to indomethacin on human 
reproduction but also open new avenues to look for 
possible contraceptives working through inhibition of 
cylooxygenase pathways.   
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